Frontier IP appoints new finance chief

12th Apr 2024 14:56

(Sharecast News) - Intellectual property commercialisation specialist Frontier IP announced the appointment of Jo Stent as its new chief financial officer on Friday, effective from 22 April.

Read more

Frontier IP's TVG appoints advisory board for herpesvirus vaccine

13th Dec 2023 14:12

(Sharecast News) - Intellectual property commercialisation specialist Frontier IP Group announced on Wednesday that its portfolio company, The Vaccine Group (TVG), had appointed an advisory board to facilitate the expansion of its herpesvirus-based vaccine platform.

Read more

UK invests in Frontier IP's Nandi Proteins business

16th Sep 2020 10:22

(Sharecast News) - The UK government has invested £360,000 in Frontier IP's portfolio company Nandi Proteins to support its efforts to replace chemical additives and fat in processed foods.

Read more

Frontier IP's Nandi Proteins gets Future Fund investment

16th Sep 2020 09:35

(Sharecast News) - Intellectual property commercialisation specialist Frontier IP said on Wednesday that its portfolio company Nandi Proteins has raised £0.72m via a convertible loan, including a £0.36m investment from the UK Government's 'Future Fund'.

Read more

Frontier IP portfolio firm Fieldwork gets another Innovate grant

14th Sep 2020 16:23

(Sharecast News) - Intellectual property investment company Frontier IP announced on Monday that Innovate UK has awarded its portfolio company Fieldwork Robotics an £84,000 continuity grant to accelerate the development of its agricultural robot technology during the Covid-19 pandemic.

Read more

Frontier IP secures EIT grant

14th Jul 2020 09:30

(Sharecast News) - Intellectual property group Frontier IP has won a grant to further develop software tools aimed at optimising wastewater treatment.

Read more

Frontier IP investment Celerum subcontracted by PlanSea Solutions

7th Jul 2020 16:13

(Sharecast News) - Intellectual property specialist Frontier IP announced on Tuesday that its portfolio company, Celerum, has been subcontracted to support software development for Aberdeen-based PlanSea Solutions.

Read more

Frontier IP portfolio firm makes progress with Covid-19 animal vaccines

23rd Jun 2020 14:13

(Sharecast News) - Shares in intellectual property commercialisation company Frontier IP were in the green on Tuesday afternoon, following an announcement from its portfolio company, the Vaccine Group (TVG) over progress made in developing animal vaccines based on its novel technology, to tackle Covid-19.

Read more

Tuesday broker round-up

9th Jun 2020 13:49

(Sharecast News) - Biffa: Citigroup downgrades to sell with a target price of 210p.

Read more

Frontier IP investment Exscientia raises $60m in series C round

26th May 2020 11:43

(Sharecast News) - Intellectual property company Frontier IP said on Tuesday that its portfolio company, AI-driven drug discovery firm Exscientia, has raised $60m (£49.1m) through a series C financing round.

Read more

Frontier IP shares rise on progress at The Vaccine Group

13th Mar 2020 14:23

(Sharecast News) - University intellectual property commercialisation company Frontier IP noted an announcement below from its portfolio company The Vaccine Group (TVG) on Friday, about the material progress it was making with its novel vaccine technology, and the start of work on a Covid-19 coronavirus vaccine for use in animals.

Read more

Frontier IP portfolio firm Fieldwork raises ?0.3m for fruit picking robot

14th Jan 2020 14:58

(Sharecast News) - Intellectual property commercialisation company Frontier IP announced on Tuesday that its portfolio company, Fieldwork Robotics, has raised £0.298m through an initial equity funding round.

Read more

Frontier IP upbeat as portfolio company partners with Bayer

10th Jan 2020 15:25

(Sharecast News) - Intellectual property commercialisation company Frontier IP announced on Friday that its portfolio company Exscientia, which focuses on artificial intelligence (AI) driven drug discovery, has entered into a collaboration with Bayer focused on cardiovascular disease and oncology.

Read more

Frontier IP profit doubles amid soaring revenues

6th Nov 2019 10:52

(Sharecast News) - Frontier IP on Wednesday reported that its annual profits more than doubled after a rise in the fair value of its investments led to a leap in revenue.

Read more

Frontier IP investee partners with Chinese biotech firm

14th Jun 2019 07:51

(Sharecast News) - Frontier IP's portfolio company Exscientia on Friday expanded its presence in Asia after it entered an AI drug discovery partnership with Shanghai-headquartered GT Apeiron Therapeutics.

Read more
1